Rescue by radiotherapy and anti-CTLA4/PD-1 after failure of anti-PD-1 therapy in patients with metastatic NSCLC: the phase II RECLAIM trial

Ezgi B Ulas, Nora D Purcell, Ilias Houda, Sayed M S Hashemi, Joris Veltman, Johannes M A Daniels, Marieke F Fransen, Teodora Radonic, Linda R Beeloo, Peter S N van Rossum, Febe van Maldegem, Nicole Barlo, Maria Disselhorst, Marjolein van Laren, Marian A Tiemessen, Svitlana Tarasevych, Jan M van Haarst, Peter van Tilburg, Peter W A Kunst, Arifa Moons-Pasic, Daniela E Oprea-Lager, Lilian J Meijboom, Natalja Bouwhuis, Tanja D de Gruijl, Suresh Senan, Famke L Schneiders, Idris Bahce

Open source

DOI
10.1136/jitc-2025-014724
Published
2026-06
Container
Journal for ImmunoTherapy of Cancer
Publisher
BMJ
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1136/jitc-2025-014724,
  title = {Rescue by radiotherapy and anti-CTLA4/PD-1 after failure of anti-PD-1 therapy in patients with metastatic NSCLC: the phase II RECLAIM trial},
  author = {Ezgi B Ulas and Nora D Purcell and Ilias Houda and Sayed M S Hashemi and Joris Veltman and Johannes M A Daniels and Marieke F Fransen and Teodora Radonic and Linda R Beeloo and Peter S N van Rossum and Febe van Maldegem and Nicole Barlo and Maria Disselhorst and Marjolein van Laren and Marian A Tiemessen and Svitlana Tarasevych and Jan M van Haarst and Peter van Tilburg and Peter W A Kunst and Arifa Moons-Pasic and Daniela E Oprea-Lager and Lilian J Meijboom and Natalja Bouwhuis and Tanja D de Gruijl and Suresh Senan and Famke L Schneiders and Idris Bahce},
  year = {2026},
  journal = {Journal for ImmunoTherapy of Cancer},
  doi = {10.1136/jitc-2025-014724},
  url = {https://doi.org/10.1136/jitc-2025-014724}
}

RIS

TY  - JOUR
TI  - Rescue by radiotherapy and anti-CTLA4/PD-1 after failure of anti-PD-1 therapy in patients with metastatic NSCLC: the phase II RECLAIM trial
AU  - Ezgi B Ulas
AU  - Nora D Purcell
AU  - Ilias Houda
AU  - Sayed M S Hashemi
AU  - Joris Veltman
AU  - Johannes M A Daniels
AU  - Marieke F Fransen
AU  - Teodora Radonic
AU  - Linda R Beeloo
AU  - Peter S N van Rossum
AU  - Febe van Maldegem
AU  - Nicole Barlo
AU  - Maria Disselhorst
AU  - Marjolein van Laren
AU  - Marian A Tiemessen
AU  - Svitlana Tarasevych
AU  - Jan M van Haarst
AU  - Peter van Tilburg
AU  - Peter W A Kunst
AU  - Arifa Moons-Pasic
AU  - Daniela E Oprea-Lager
AU  - Lilian J Meijboom
AU  - Natalja Bouwhuis
AU  - Tanja D de Gruijl
AU  - Suresh Senan
AU  - Famke L Schneiders
AU  - Idris Bahce
PY  - 2026
JO  - Journal for ImmunoTherapy of Cancer
DO  - 10.1136/jitc-2025-014724
UR  - https://doi.org/10.1136/jitc-2025-014724
ER  - 

APA

Ulas, E. B., Purcell, N. D., Houda, I., Hashemi, S. M. S., Veltman, J., Daniels, J. M. A., Fransen, M. F., Radonic, T., Beeloo, L. R., Rossum, P. S. N. V., Maldegem, F. V., Barlo, N., Disselhorst, M., Laren, M. V., Tiemessen, M. A., Tarasevych, S., Haarst, J. M. V., Tilburg, P. V., Kunst, P. W. A., Moons-Pasic, A., Oprea-Lager, D. E., Meijboom, L. J., Bouwhuis, N., Gruijl, T. D. D., Senan, S., Schneiders, F. L., & Bahce, I. (2026). Rescue by radiotherapy and anti-CTLA4/PD-1 after failure of anti-PD-1 therapy in patients with metastatic NSCLC: the phase II RECLAIM trial. Journal for ImmunoTherapy of Cancer. https://doi.org/10.1136/jitc-2025-014724

Source records